Basic Information
ID: ALA4687212
Type: Functional
Description: Antiviral activity against HIV-1 NL4-3 infected in human TZM-bl cells infected with supernatants from virus-infected human H9 cells treated with compound for 72 hrs assessed as reduction in luciferase expression measured after 48 hrs by luciferase reporter gene assay based BiCycle assay
Organism: Human immunodeficiency virus 1
Strain: NL4-3
Activity Charts
Bioactivity
Activity Types for Assay ALA4687212
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 349.44 | 4.56 | 4.56 |
| 497.55 | 2.38 | 2.38 |
| 473.47 | 4.96 | 4.96 |
| 433.56 | 5.88 | 5.88 |
| 386.46 | 4.80 | 4.80 |
| 400.49 | 5.05 | 5.05 |
| 475.47 | 5.06 | 5.06 |
| 391.35 | 3.46 | 3.46 |
| 501.52 | 6.12 | 6.12 |
| 393.49 | 4.88 | 4.88 |
| 435.53 | 4.73 | 4.73 |
| 447.42 | 4.43 | 4.43 |